Yifan Pharmaceutical Co., Ltd. (SHE:002019)
China
· Delayed Price · Currency is CNY 12.10
+0.61 (5.31%)
May 13, 2025, 3:04 PM CST
Yifan Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 874.3 | 889.39 | 698.37 | 1,144 | 1,336 | 1,324 | Upgrade
|
| Trading Asset Securities | - | - | 75.01 | 95.5 | - | 46.73 | Upgrade
|
| Cash & Short-Term Investments | 874.3 | 889.39 | 773.38 | 1,239 | 1,336 | 1,371 | Upgrade
|
| Cash Growth | 4.64% | 15.00% | -37.59% | -7.25% | -2.51% | -12.30% | Upgrade
|
| Accounts Receivable | 1,560 | 1,507 | 1,209 | 1,258 | 1,145 | 1,102 | Upgrade
|
| Other Receivables | 113.46 | 105.57 | 80.69 | 112.08 | 120.16 | 130.17 | Upgrade
|
| Receivables | 1,673 | 1,612 | 1,290 | 1,370 | 1,265 | 1,232 | Upgrade
|
| Inventory | 1,100 | 1,056 | 928.61 | 830.97 | 663.87 | 583.85 | Upgrade
|
| Other Current Assets | 254.74 | 220.86 | 259.62 | 249.71 | 320.22 | 319.35 | Upgrade
|
| Total Current Assets | 3,902 | 3,778 | 3,251 | 3,690 | 3,585 | 3,506 | Upgrade
|
| Property, Plant & Equipment | 2,288 | 2,144 | 1,752 | 1,601 | 1,643 | 1,491 | Upgrade
|
| Long-Term Investments | 700.14 | 691.26 | 717.04 | 696.68 | 640.12 | 666.23 | Upgrade
|
| Goodwill | 2,737 | 2,737 | 2,737 | 2,738 | 2,738 | 2,750 | Upgrade
|
| Other Intangible Assets | 1,774 | 1,826 | 1,683 | 751.37 | 658.21 | 715.63 | Upgrade
|
| Long-Term Accounts Receivable | 17.73 | 17.74 | 1.43 | 2.16 | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 248.3 | 245.21 | 257.81 | 291.47 | 244.38 | 226.34 | Upgrade
|
| Long-Term Deferred Charges | 772.6 | 773.65 | 964.14 | 2,592 | 2,474 | 2,187 | Upgrade
|
| Other Long-Term Assets | 71.68 | 72.29 | 136.08 | 181.38 | 182.71 | 95.33 | Upgrade
|
| Total Assets | 12,511 | 12,286 | 11,500 | 12,544 | 12,165 | 11,637 | Upgrade
|
| Accounts Payable | 685.36 | 609.12 | 431.36 | 288.4 | 350.86 | 381.19 | Upgrade
|
| Accrued Expenses | 106.95 | 393.79 | 387.69 | 360.56 | 219.84 | 180.43 | Upgrade
|
| Short-Term Debt | 998.82 | 1,058 | 609.05 | 673.96 | 1,020 | 1,193 | Upgrade
|
| Current Portion of Long-Term Debt | 336.15 | 544.67 | 489.77 | 554.03 | 419.27 | 17.67 | Upgrade
|
| Current Portion of Leases | - | 14.22 | 17.6 | 17.95 | 14.54 | 0.49 | Upgrade
|
| Current Income Taxes Payable | 62.62 | 29.21 | 19.14 | 29.54 | 24.19 | 33.8 | Upgrade
|
| Current Unearned Revenue | 118.71 | 113.63 | 133.23 | 203.26 | 94.82 | 62.68 | Upgrade
|
| Other Current Liabilities | 540.01 | 224.76 | 99.53 | 71.69 | 158.53 | 259.6 | Upgrade
|
| Total Current Liabilities | 2,849 | 2,987 | 2,187 | 2,199 | 2,302 | 2,129 | Upgrade
|
| Long-Term Debt | 839.51 | 627.16 | 812.04 | 850.17 | 730.51 | 447.63 | Upgrade
|
| Long-Term Leases | 47.39 | 50.56 | 66.73 | 80.69 | 89.8 | 0.95 | Upgrade
|
| Long-Term Unearned Revenue | 113.42 | 121.21 | 102.16 | 107.29 | 104.12 | 88.36 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 45.42 | 46.51 | 54.52 | 140.9 | 148.28 | 225.13 | Upgrade
|
| Other Long-Term Liabilities | 28.67 | 26.49 | 21.86 | 18.94 | 16.02 | - | Upgrade
|
| Total Liabilities | 3,923 | 3,859 | 3,245 | 3,397 | 3,391 | 2,907 | Upgrade
|
| Common Stock | 1,037 | 1,037 | 1,046 | 1,046 | 1,054 | 1,055 | Upgrade
|
| Additional Paid-In Capital | 2,848 | 2,848 | 2,993 | 2,993 | 3,048 | 3,041 | Upgrade
|
| Retained Earnings | 4,772 | 4,618 | 4,354 | 4,905 | 4,712 | 4,505 | Upgrade
|
| Treasury Stock | - | - | -159 | -121.01 | -186.72 | -127.02 | Upgrade
|
| Comprehensive Income & Other | 41.35 | 18.96 | 41.31 | -11.36 | -92.36 | -34.22 | Upgrade
|
| Total Common Equity | 8,697 | 8,522 | 8,276 | 8,812 | 8,535 | 8,440 | Upgrade
|
| Minority Interest | -109.56 | -95.07 | -20.73 | 334.75 | 239.38 | 290.36 | Upgrade
|
| Shareholders' Equity | 8,588 | 8,427 | 8,255 | 9,147 | 8,775 | 8,730 | Upgrade
|
| Total Liabilities & Equity | 12,511 | 12,286 | 11,500 | 12,544 | 12,165 | 11,637 | Upgrade
|
| Total Debt | 2,222 | 2,294 | 1,995 | 2,177 | 2,274 | 1,660 | Upgrade
|
| Net Cash (Debt) | -1,348 | -1,405 | -1,222 | -937.51 | -937.76 | -289.32 | Upgrade
|
| Net Cash Per Share | -1.12 | -1.16 | -1.00 | -0.74 | -0.77 | -0.24 | Upgrade
|
| Filing Date Shares Outstanding | 1,217 | 1,216 | 1,216 | 1,219 | 1,207 | 1,148 | Upgrade
|
| Total Common Shares Outstanding | 1,217 | 1,216 | 1,216 | 1,219 | 1,207 | 1,148 | Upgrade
|
| Working Capital | 1,053 | 791.21 | 1,064 | 1,491 | 1,284 | 1,377 | Upgrade
|
| Book Value Per Share | 7.15 | 7.01 | 6.80 | 7.23 | 7.07 | 7.35 | Upgrade
|
| Tangible Book Value | 4,186 | 3,958 | 3,855 | 5,323 | 5,139 | 4,975 | Upgrade
|
| Tangible Book Value Per Share | 3.44 | 3.25 | 3.17 | 4.37 | 4.26 | 4.33 | Upgrade
|
| Buildings | - | 985.62 | 973.8 | 914.2 | 931.78 | 841.79 | Upgrade
|
| Machinery | - | 1,458 | 1,443 | 1,357 | 1,232 | 1,071 | Upgrade
|
| Construction In Progress | - | 807.15 | 313.31 | 175.8 | 257.46 | 415.22 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.